138 related articles for article (PubMed ID: 12352359)
1. The relationship between müllerian inhibiting substance and androgens in boys with hypospadias.
Austin PF; Siow Y; Fallat ME; Cain MP; Rink RC; Casale AJ
J Urol; 2002 Oct; 168(4 Pt 2):1784-8; discussion 1788. PubMed ID: 12352359
[TBL] [Abstract][Full Text] [Related]
2. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
[TBL] [Abstract][Full Text] [Related]
3. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
[TBL] [Abstract][Full Text] [Related]
4. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism.
Misra M; MacLaughlin DT; Donahoe PK; Lee MM
J Clin Endocrinol Metab; 2002 Aug; 87(8):3598-602. PubMed ID: 12161481
[TBL] [Abstract][Full Text] [Related]
5. Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.
Trbovich AM; Sluss PM; Laurich VM; O'Neill FH; MacLaughlin DT; Donahoe PK; Teixeira J
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3393-7. PubMed ID: 11248089
[TBL] [Abstract][Full Text] [Related]
6. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.
Rey R; Lordereau-Richard I; Carel JC; Barbet P; Cate RL; Roger M; Chaussain JL; Josso N
J Clin Endocrinol Metab; 1993 Nov; 77(5):1220-6. PubMed ID: 8077315
[TBL] [Abstract][Full Text] [Related]
7. Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
Laurich VM; Trbovich AM; O'Neill FH; Houk CP; Sluss PM; Payne AH; Donahoe PK; Teixeira J
Endocrinology; 2002 Sep; 143(9):3351-60. PubMed ID: 12193547
[TBL] [Abstract][Full Text] [Related]
8. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.
Lee MM; Donahoe PK; Silverman BL; Hasegawa T; Hasegawa Y; Gustafson ML; Chang YC; MacLaughlin DT
N Engl J Med; 1997 May; 336(21):1480-6. PubMed ID: 9154766
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of mullerian inhibiting substance in boys throughout puberty and in the first two years of life.
Baker ML; Hutson JM
J Clin Endocrinol Metab; 1993 Jan; 76(1):245-7. PubMed ID: 8421093
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women.
Cook CL; Siow Y; Brenner AG; Fallat ME
Fertil Steril; 2002 Jan; 77(1):141-6. PubMed ID: 11779604
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of Mullerian inhibiting substance in boys with cryptorchidism.
Yamanaka J; Baker M; Metcalfe S; Hutson JM
J Pediatr Surg; 1991 May; 26(5):621-3. PubMed ID: 1676417
[TBL] [Abstract][Full Text] [Related]
12. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice.
Wu X; Arumugam R; Baker SP; Lee MM
Endocrinology; 2005 Feb; 146(2):589-95. PubMed ID: 15514087
[TBL] [Abstract][Full Text] [Related]
13. Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities.
Gustafson ML; Lee MM; Asmundson L; MacLaughlin DT; Donahoe PK
J Pediatr Surg; 1993 Mar; 28(3):439-44. PubMed ID: 8468660
[TBL] [Abstract][Full Text] [Related]
14. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.
Lee MM; Donahoe PK; Hasegawa T; Silverman B; Crist GB; Best S; Hasegawa Y; Noto RA; Schoenfeld D; MacLaughlin DT
J Clin Endocrinol Metab; 1996 Feb; 81(2):571-6. PubMed ID: 8636269
[TBL] [Abstract][Full Text] [Related]
15. Anti-müllerian hormone in children with androgen insensitivity.
Rey R; Mebarki F; Forest MG; Mowszowicz I; Cate RL; Morel Y; Chaussain JL; Josso N
J Clin Endocrinol Metab; 1994 Oct; 79(4):960-4. PubMed ID: 7962305
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of müllerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay.
Baker ML; Metcalfe SA; Hutson JM
J Clin Endocrinol Metab; 1990 Jan; 70(1):11-5. PubMed ID: 2403569
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the P450 c17 (17-hydroxylase/17, 20-Lyase) gene: association with estradiol and testosterone concentration in hypospadias.
Yadav CS; Bajpai M; Kumar V; Datta SK; Gupta P; Ahmed RS; Banerjee BD
Urology; 2011 Oct; 78(4):902-7. PubMed ID: 21676446
[TBL] [Abstract][Full Text] [Related]
18. An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.
Hudson PL; Dougas I; Donahoe PK; Cate RL; Epstein J; Pepinsky RB; MacLaughlin DT
J Clin Endocrinol Metab; 1990 Jan; 70(1):16-22. PubMed ID: 2294129
[TBL] [Abstract][Full Text] [Related]
19. Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.
Wu X; Zhang N; Lee MM
Endocrinology; 2012 Oct; 153(10):4929-37. PubMed ID: 22872577
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of müllerian inhibiting substance in preterm and term male neonates.
Schwindt B; Doyle LW; Hutson JM
J Urol; 1997 Aug; 158(2):610-2. PubMed ID: 9224378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
